NQO1 activation: A novel antihypertensive treatment strategy?

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)233-235
Number of pages3
JournalJournal of Hypertension
Volume32
Issue number2
DOIs
StatePublished - Feb 2014

Fingerprint

GTP Cyclohydrolase
NAD(P)H Dehydrogenase (Quinone)
AMP-Activated Protein Kinases
Nitric Oxide Synthase Type III
Protein-Serine-Threonine Kinases
Antihypertensive Agents
Hypertension

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

NQO1 activation : A novel antihypertensive treatment strategy? / Hale, Taben.

In: Journal of Hypertension, Vol. 32, No. 2, 02.2014, p. 233-235.

Research output: Contribution to journalArticle

@article{37eb5c14325a469c8458b35ecc5d9677,
title = "NQO1 activation: A novel antihypertensive treatment strategy?",
author = "Taben Hale",
year = "2014",
month = "2",
doi = "10.1097/HJH.0000000000000057",
language = "English (US)",
volume = "32",
pages = "233--235",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - NQO1 activation

T2 - A novel antihypertensive treatment strategy?

AU - Hale, Taben

PY - 2014/2

Y1 - 2014/2

UR - http://www.scopus.com/inward/record.url?scp=84892955070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892955070&partnerID=8YFLogxK

U2 - 10.1097/HJH.0000000000000057

DO - 10.1097/HJH.0000000000000057

M3 - Article

C2 - 24430120

AN - SCOPUS:84892955070

VL - 32

SP - 233

EP - 235

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 2

ER -